首页> 外文期刊>Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions >Transcatheter aortic valve implantation for severe aortic regurgitation in a stentless bioprosthetic valve with the core valve revalving system-technical tips and role of the Accutrak system.
【24h】

Transcatheter aortic valve implantation for severe aortic regurgitation in a stentless bioprosthetic valve with the core valve revalving system-technical tips and role of the Accutrak system.

机译:经导管主动脉瓣膜植入术用于无支架生物假体瓣膜中的严重主动脉瓣反流,其核心瓣膜瓣回注系统,技术技巧和Accutrak系统的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Transcatheter aortic valve implantation may offer a less invasive alternate to surgical reoperation in patients with failed aortic bioprosthetic valves. Prior reports have focussed on successful transcatheter treatment of stented bioprosthesis. Newer stentless valves offer unique technical challenges. In the absence of radiopaque markers, the deployment is carried out under angiographic control. Device stability is also an important issue in cases of severe regurgitation. We report on the first case of percutaneous replacement of a severely regurgitant degenerated stentless bioprosthesis treated with the new iteration of the core valve system incorporating the Accutrak stability layer. Salient technical expedients have been mentioned and discussed in detail.
机译:经主动脉生物瓣膜衰竭的患者,经导管主动脉瓣膜植入术可提供较无创的手术再手术替代方案。先前的报道集中于成功的经支架置入的生物假体的经导管治疗。新型无支架瓣膜提出了独特的技术挑战。在不透射线标记物不存在的情况下,展开是在血管造影控制下进行的。在严重的反流情况下,设备的稳定性也是一个重要的问题。我们报道了第一例经皮置换的严重反流性退化无支架生物假体,该假体经结合了Accutrak稳定层的核心瓣膜系统的新迭代处理。已经提到并详细讨论了显着的技术权宜之计。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号